Med Page Today

NOVEMBER 8, 2024

(MedPage Today) -- SAN ANTONIO -- Use of an oral biodegradable drug-free capsule led to more weight loss among patients with overweight or obesity compared with placebo, according to the randomized RESET trial. Among 279 patients, mean change.

Obesity 116

Obesity 116

HCPLive

NOVEMBER 26, 2024

The investigators of this study noted an association between obesity and conditions such as rosacea, psoriasis, and lichen simplex chronicus.

Obesity 114

Obesity 114

American Heart News - Heart News

JANUARY 17, 2024

Research Highlights: Consistently high scores of perceived stress during adolescence through adulthood may contribute to worse cardiometabolic health including obesity in young adults. Researchers suggest the adoption of healthy coping strategies.

Obesity 134

Obesity Blood Pressure Diabetes Research 134

HCPLive

JANUARY 25, 2024

After adjusting for confounders, data revealed higher levels of obesity indices were linked with a gradual and dose-dependent increase in urate levels.

Obesity 115

Obesity 115

HCPLive

NOVEMBER 17, 2024

Obesity-related ischemic heart disease deaths rose from 1999 to 2020, particularly in middle-aged men and Black adults, per CDC WONDER data.

Obesity 111

Obesity Heart Disease 111

Med Page Today

JULY 5, 2024

(MedPage Today) -- GLP-1 receptor agonists lowered the risk of several obesity-associated cancers, a retrospective analysis of electronic health records suggested. Compared with insulin, GLP-1s were associated with a lower risk for developing.

Obesity 115

Obesity Cancer Diabetes 115

Med Page Today

APRIL 18, 2024

(MedPage Today) -- Tirzepatide (Zepbound) injections reduced sleep apnea severity among patients with obesity, regardless of positive airway pressure (PAP) use, according to topline data from two phase III trials. In the SURMOUNT-OSA 1 study.

Obesity 113

Obesity 113

Journal of Clinical Investigation - Cardiology

SEPTEMBER 17, 2024

Obesity is linked to an increased risk of atrial fibrillation (AF) via increased oxidative stress. Here, we studied NOX2-mediated ROS production in obesity-mediated AF using Nox2-knockout mice and mature human induced pluripotent stem cell–derived atrial cardiomyocytes (hiPSC-aCMs).

Obesity 97

Obesity Atrial Fibrillation Diet 97

HCPLive

FEBRUARY 5, 2024

Tirzepatide, a dual GLP-1/GIP agonist approved for diabetes and obesity, was associated with significant blood pressure reductions in an analysis of the SURMOUNT-1 trial.

Blood Pressure 116

Blood Pressure Obesity Diabetes 116

HCPLive

DECEMBER 23, 2024

Glycemic control continues to be a major risk factor for diabetic retinopathy, while overweight, obesity, and hypertension are growing in prevalence.

Risk Factors 111

Risk Factors Obesity Diabetes Hypertension 111

HCPLive

FEBRUARY 2, 2024

Obesity was linked to an increased risk of focal segmental glomerulosclerosis and hypertensive nephropathy, with further analysis revealing its impact on the risk of developing end-stage kidney disease.

Kidney Disease 105

Kidney Disease Obesity Hypertension 105

Med Page Today

JANUARY 14, 2025

(MedPage Today) -- Medical experts from around the globe proposed a more nuanced approach to diagnosing obesity that does not rely exclusively on body mass index (BMI) alone. Writing in The Lancet Diabetes & Endocrinology, the global commission.

Obesity 93

Obesity BMI Diabetes 93

HCPLive

JUNE 29, 2024

Patients with RA and obesity exhibited worse scores for subjective measures like pain and fatigue compared to those without obesity.

Obesity 98

Obesity Outcomes 98

HCPLive

SEPTEMBER 18, 2024

The new guidance reviews existing tools for weight management and provides recommendations for their use in clinical practice in patients with obesity and kidney disease.

Kidney Disease 104

Kidney Disease Obesity 104

HCPLive

FEBRUARY 14, 2024

Patients with ACPA-positive RA and obesity had greater DAS44 scores compared to normal-weight patients, although this difference was not present in ACPA-negative RA.

Obesity 105

Obesity 105

HCPLive

DECEMBER 16, 2024

Laurence Sperling, MD shares insights into a multi-disciplinary approach to the management of obesity from the perspective of a cardiologist.

Obesity 98

Obesity 98

HCPLive

OCTOBER 15, 2024

Study findings showed children with both obesity and MASLD have a greater risk of youth-onset type 2 diabetes than those with obesity alone.

Obesity 98

Obesity Diabetes 98

Journal of Clinical Investigation - Cardiology

FEBRUARY 1, 2024

Nonalcoholic fatty liver disease (NAFLD) is prevalent in the majority of individuals with obesity, but in a subset of these individuals, it progresses to nonalcoholic steatohepatitis (0NASH) and fibrosis. The mechanisms that prevent NASH and fibrosis in the majority of patients with NAFLD remain unclear.

Obesity 106

Obesity Diet 106

American Heart News - Heart News

SEPTEMBER 5, 2024

Research Highlights: In an analysis of 18 randomized clinical trials, people with obesity and high blood pressure who underwent bariatric (weight-loss) surgery were almost three times more likely to achieve blood pressure remission, defined as.

Blood Pressure 109

Blood Pressure Obesity Research 109

American Heart News - Heart News

NOVEMBER 16, 2024

called SUMMIT, participants with heart failure with preserved ejection fraction (HFpEF) and obesity taking tirzepatide for an average of 2 years had. Research Highlights: In an international trial of 713 adults in nine countries including the U.S.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Heart Failure Obesity Research 105

Med Page Today

JANUARY 21, 2025

(MedPage Today) -- Beneficial pediatric obesity treatment response was associated with a reduced risk of obesity-related events in young adults, a nationwide prospective cohort study in Sweden showed. Compared with poor response, good response.

Obesity 80

Obesity Pediatrics Outcomes 80

Cardiovascular Diabetology

SEPTEMBER 15, 2024

Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovascular disease. Conclusions The findings suggest that fenofibrate may be a useful therapeutic agent for obesity- and diabetes-related cardiomyopathy.

Obesity 98

Obesity Heart Failure Diabetes Cardiomyopathy 98

Cardiometabolic Health Congress

JANUARY 3, 2024

In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

Becker's Hospital Review - Cardiology

NOVEMBER 13, 2024

Between 1999 and 2020, obesity-related deaths from heart disease deaths in the U.S. increased by 180%, according to a preliminary study to be presented at the American Heart Association's annual Scientific Sessions, set for Nov.

Obesity 96

Obesity Heart Disease 96

Frontiers in Cardiovascular Medicine

MARCH 7, 2024

We initiated a mobilization program, but the patient's mobility was highly limited due to severe obesity and symptomatic orthostatic hypotension. B-SES could be an option for patients with heart failure who have limited mobility and obesity. B-SES was introduced to accomplish weight loss and early ambulation.

Heart Failure 124

Heart Failure Obesity Heart Transplant Transplant 124

Med Page Today

SEPTEMBER 10, 2024

(MedPage Today) -- Liraglutide (Saxenda) added to lifestyle intervention helped reduce BMI in young children with obesity, the phase IIIa SCALE Kids trial found. By week 56, kids, ages 6 to <12 years, on once-daily 3-mg liraglutide lost 5.8.

BMI 99

BMI Obesity 99

Med Page Today

NOVEMBER 16, 2024

(MedPage Today) -- CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and accompanying heart failure with preserved ejection fraction (HFpEF), according to the SUMMIT trial. Incident.

Preserved Ejection Fraction 101

Preserved Ejection Fraction Heart Failure Obesity 101

Medical Xpress - Cardiology

JULY 9, 2024

Researchers from King's have identified evidence to suggest that lifestyle changes could offset the risk of some adult heart disorders that result from maternal obesity and changes in fetal heart development.

Obesity 97

Obesity Diet Exercise Research 97

Med Page Today

OCTOBER 2, 2024

(MedPage Today) -- The novel investigational weight loss agent HU6 had mixed results specifically targeting obesity-related heart failure with preserved ejection fraction (HFpEF), based on the small HuMain-HFpEF trial. After 19 weeks on daily.

Preserved Ejection Fraction 97

Preserved Ejection Fraction Obesity Heart Failure 97

American Heart News - Heart News

NOVEMBER 11, 2024

who died from ischemic heart disease related to obesity increased by approximately 180% from 1999 to 2020. American Heart Association Scientific Sessions 2024, Abstract AC.MDP.13 13 - An analysis of data from the CDC’s WONDER database found that the number of people in the U.S.

Obesity 98

Obesity Heart Disease 98

Medical Xpress - Cardiology

NOVEMBER 27, 2024

The rate of deaths from ischemic heart disease related to obesity nearly tripled in the U.S. over a two-decade span, according to new research. The rate for men more than tripled.

Obesity 98

Obesity Heart Disease Research 98

Science Daily - Heart Disease

JANUARY 17, 2024

Young adults who reported higher stress as adolescents were more likely to have high blood pressure, obesity and other cardiometabolic risk factors as adults, finds new study.

Blood Pressure 100

Blood Pressure Obesity Risk Factors Diabetes 100

Medical Xpress - Cardiology

JANUARY 16, 2024

Obesity-induced heart disease, which affects up to 10% of the population in certain age ranges, is considered an untreatable condition and 75% of people don't survive more than five years beyond diagnosis.

Obesity 91

Obesity Heart Disease Research 91

Med Page Today

MARCH 8, 2024

(MedPage Today) -- Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like semaglutide (Wegovy) are facing a new dilemma: What happens if they stop taking them? Many worry, rightly, that they'll.

Obesity 91

Obesity 91

Circulation

MAY 20, 2024

Obesity is a recognized public health epidemic with a prevalence that continues to increase dramatically in nearly all populations, impeding progress in reducing incidence rates of cardiovascular disease. Circulation, Ahead of Print.

Obesity 78

Obesity Public Health Research Cardiovascular Disease 78

HCPLive

JUNE 23, 2024

In the special on-site ADA 2024 episode, hosts are joined by the ADA's Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, to discuss the newly formed Obesity Association.

Obesity 83

Obesity Diabetes 83

Cardiovascular Diabetology

APRIL 1, 2024

Obesity is often associated with multiple comorbidities. However, whether obese subjects with hyperlipidemia in the absence of other complications have worse cardiac indices than metabolically healthy obese su.

Obesity 84

Obesity Research 84